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Abstract
The innate immune response is essential for controlling West Nile virus (WNV) infection but how this response is propagated
and regulates adaptive immunity in vivo are not defined. Herein, we show that IPS-1, the central adaptor protein to RIG-I-like
receptor (RLR) signaling, is essential for triggering of innate immunity and for effective development and regulation of
adaptive immunity against pathogenic WNV. IPS-1
2/2 mice exhibited increased susceptibility to WNV infection marked by
enhanced viral replication and dissemination with early viral entry into the CNS. Infection of cultured bone-marrow (BM)
derived dendritic cells (DCs), macrophages (Macs), and primary cortical neurons showed that the IPS-1-dependent RLR
signaling was essential for triggering IFN defenses and controlling virus replication in these key target cells of infection.
Intriguingly, infected IPS-1
2/2 mice displayed uncontrolled inflammation that included elevated systemic type I IFN,
proinflammatory cytokine and chemokine responses, increased numbers of inflammatory DCs, enhanced humoral
responses marked by complete loss of virus neutralization activity, and increased numbers of virus-specific CD8+ T cells and
non-specific immune cell proliferation in the periphery and in the CNS. This uncontrolled inflammatory response was
associated with a lack of regulatory T cell expansion that normally occurs during acute WNV infection. Thus, the enhanced
inflammatory response in the absence of IPS-1 was coupled with a failure to protect against WNV infection. Our data define
an innate/adaptive immune interface mediated through IPS-1-dependent RLR signaling that regulates the quantity, quality,
and balance of the immune response to WNV infection.
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Introduction
West Nile virus (WNV) is a neurotropic flavivirus and is an
emerging public health threat. Infection with WNV now constitutes
the leading cause of mosquito-borne and epidemic encephalitis in
humans in the United States [1]. WNV is enveloped and contains a
single strand positive sense RNA genome of approximately 11 kb in
length that encodes three structural (C, prM/M, and E) and seven
non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B,
and NS5). It cycles enzootically between birds and Culex
mosquitoes, with humans infected as dead-end hosts. WNV
infection has been modeled in inbred mice wherein infection and
pathogenesis recapitulate many of the features of human infection
(reviewed in [2]). Following subcutaneous inoculation, WNV
replicates in dendritic cells (DCs) at the portal of entry and in the
draining lymph node. A primary viremia develops and virus
spreads to visceral organs including the spleen, where further
amplification occurs, leading to central nervous system (CNS)
dissemination and encephalitis. In humans, WNV causes an acute
febrile illness that can progress to severe and sometimes lethal
neuroinvasive disease, especially in the elderly and immunocom-
promised [3]. However, healthy young adults are also afflicted with
severe neurological disease [4,5,6], indicating that virulence can
occur independently of immune deficiencies or aging.
Intracellular innate immune defenses and the actions of type I
interferon (IFN) provide a first-line of defense against virus infection
and are essential for the control of WNV replication, dissemination,
and neurovirulence [7]. Innate antiviral immune defenses are
triggered through the recognition of conserved pathogen associated
molecular pattern (PAMP) motifs within viral products by
intracellular pathogen recognition receptor (PRR) proteins in
infected cells. PRR signaling directs downstream activation of latent
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(IRF)-3 and IRF-7, in a cell type-specific manner to induce antiviral
response programs that include expression of proinflammatory
cytokines, chemokines, type I IFN, and interferon stimulated genes
(ISGs) [7,8,9,10]. The ISG products induced through autocrine and
paracrine actions of IFN confer antiviral activity by limiting virus
replication and cell-to-cell virus spread. Modulation of IFN signaling
has been identified as a virulence feature of pathogenic strains of
WNV [11,12].
The RLRs, retinoic acid inducible gene-I (RIG-I) and
melanoma differentiation antigen 5 (MDA5) [13,14,15,16], are
PRRs that play critical roles in triggering immune defenses against
RNA virus infection, including WNV. RIG-I and MDA5 are
cytosolic RNA helicases that contain an amino terminal tandem
caspase activation and recruitment domain (CARD). Upon
engaging RNA substrates, the RLRs undergo a conformational
change and bind to the mitochondrial associated protein,
interferon promoter stimulator-1 (IPS-1) through a CARD-CARD
interaction, leading to IPS-1-dependent signaling of IFN produc-
tion and expression of immune response genes [17,18]. RLR
signaling and IPS-1 function have an essential role in triggering
IFN defenses during WNV infection of mouse embryo fibroblasts
(MEFs) and human cell lines in vitro. Cells lacking either RIG-I or
MDA5 were attenuated in their ability to generate an effective
innate immune response to infection, whereas cells lacking both
RIG-I and MDA5 or those deficient in IPS-1 alone were unable to
respond to infection with WNV and related flaviviruses
[19,20,21,22]. Recent studies examined the role of another class
of pattern recognition receptors, Toll like receptor (TLR)3 and
TLR7, and show that these receptors are also important PRRs of
WNV infection, as they play a role in signaling IFN production
and an inflammatory response upon viral ligand recognition
[23,24,25]. TLR3 has been shown to contribute to both
enhancement and protection of CNS inflammation and neurovir-
ulence of WNV in vivo [23,24], while TLR7-dependent signaling
was shown to be essential for directing proper immune cell homing
to sites of WNV infection during the adaptive immune response in
vivo [25].
Type I IFN, a major product of PRR signaling, has been shown
to link innate and adaptive immune responses. However, the
specific PRR pathways that mediate this during acute WNV
infection have not been delineated nor has the RLR pathway been
evaluated in this context. The quantity and quality of the innate
and adaptive immune responses after infection must be carefully
regulated to avoid aberrant inflammation and immunopathogen-
esis. Regulatory T (Treg) cells and inflammatory dendritic cell (DC)
subsets regulate inflammation during acute virus infection through
T cell suppression and by modulating the trafficking and
inflammatory cytokine production of immune cells into infected
tissues [26,27,28]. Thus, the level of local and peripheral Treg cells,
and the composition of local DC subsets that develop during
WNV infection may determine immune control and WNV
disease.
H e r e ,w ea s s e s s e dt h er o l eo fR L Rs i g n a l i n ga n dI P S - 1i nW N V
infection and immunity. Our studies define IPS-1 as an essential
modulator of immunity in vivo and demonstrate that IPS-1-dependent
signaling orchestrates an innate/adaptive immune interface that
regulates immune responses to effectively control WNV infection.
Results
RIG-I and IPS-1 are essential for protection against WNV
infection
WNV infection of primary embryonic fibroblasts recovered
from RIG-I
2/2 mice revealed that RIG-I was important in
eliciting innate antiviral immune defenses early during infection,
whereas MDA5 was important for enhancing and sustaining this
response [21]. We further evaluated WNV infection of RIG-I
2/2
or MDA5
2/2 mice and confirmed that RIG-I serves a dominant
role among the RLRs for the acute induction of innate immune
defenses and protection against WNV infection in vivo (data not
shown). Since the RLRs signal innate defenses through the IPS-1
adaptor protein [29], we also examined the role of IPS-1 in
protection against WNV infection upon a sub-lethal virus
challenge of wild type and IPS-1
2/2 mice. IPS-1
2/2 mice were
highly susceptible to WNV infection and exhibited 100% mortality
with an average survival time (AST) of 7.3 days as compared to
wild type mice (38.5% mortality with an AST of 13.2 days;
p,0.0001; Fig 1A). Thus, RIG-I and IPS-1-dependent signaling
are essential for protection against WNV infection.
IPS-1-dependent signaling controls WNV replication,
tissue tropism, and CNS invasion
To define the role of IPS-1 in controlling WNV in vivo, wild type
and IPS-1
2/2 mice were infected subcutaneously (s.c.) with 100
PFU of WN-TX and viral burden within peripheral tissues and the
CNS was measured over time post-infection (pi). IPS-1
2/2 mice
exhibited increased viremia compared to wild type mice (45.7 fold
enhancement at day 1 pi, P,0.05) throughout the course of
infection (Fig 1B). Similarly, viral loads in the spleen were
elevated in the infected IPS-1
2/2 mice (Fig 1C). WNV infection
of IPS-1
2/2 mice displayed an expanded tissue tropism as
infectious virus was found in the kidneys, a tissue that is not
normally permissive to infection in wild type mice (Fig 1D). WNV
is typically detected in the CNS of wild type mice after s.c.
challenge between 4 and 8 days pi [2]. Consistent with this time
course, infected wild type mice exhibited detectable viral loads
(average viral titer of 10
1.8 pfu/gram of tissue) in the brain by day
6 p.i., although virus was not detected in the spinal cord (Fig 1E
and F). In contrast, WNV spread to the brain (Fig 1E) and spinal
cord of IPS-1
2/2 mice (Fig 1F) by day 2 pi, with viral loads rising
through day 6 pi. Together these results indicate that IPS-1, likely
Author Summary
West Nile virus (WNV) is a mosquito-transmitted RNA virus
that has emerged in the Western hemisphere and is now
the leading cause of arboviral encephalitis in the United
States. However, the virus/host interface that controls
WNV pathogenesis is not well understood. Previous
studies have established that the innate immune response
and interferon (IFN) defenses are essential for controlling
virus replication and dissemination. In this study, we
assessed the importance of the RIG-I like receptor (RLR)
signaling pathway in WNV pathogenesis through analysis
of mice lacking IPS-1, the central adaptor molecule of RLR
signaling. Our studies revealed that IPS-1 is essential for
protection against WNV infection and that it regulates
processes that control virus replication and triggering of
innate immune defenses. We found that IPS-1 plays an
important role in establishing adaptive immunity through
an innate/adaptive interface that elicits effective antibody
responses and controls the expansion of regulatory T cells.
Thus, RLRs are essential for pathogen recognition of WNV
infection and their signaling programs help orchestrate
immune response maturation, regulation of inflammation,
and immune homeostasis that define the outcome of WNV
infection.
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replication, viremia, and peripheral spread, and is essential for the
control of viral invasion of the CNS.
IPS-1 regulates the innate immune response to WNV
infection in myeloid cells
Myeloid cells, including tissue and lymphoid DC and
macrophages (Mw), are among the first cells to encounter
WNV during infection and thus function to restrict the spread
of virus to distant tissues and the CNS [2]. To define the role of
IPS-1 in controlling virus replication and innate immunity in
myeloid cells, we analyzed WNV infection and host responses in
primary bone marrow-derived DC and Mw recovered from wild
type and IPS-1
2/2 mice. DC and Mw were infected at an MOI
of 1.0 (relative to viral plaque assay quantification of BHK-21
cells; see Methods) and evaluated for virus replication, IFN
induction, and innate immune triggering of ISG expression
(Fig 2). IPS-1
2/2 DCs sustained significantly higher WNV
replication at 36 and 48 hours pi compared to wild type infected
cells (Fig 2A). WNV infection of wild type DCs induced IFN-b
secretion but this response was completely abolished in IPS-1
2/2
DCs (Fig 2B). The lack of IFN-b induction in IPS-1
2/2 DCs
correlated with a lack of ISG expression including RIG-I, MDA5,
and STAT-1 (Fig 2C). In addition, expression of ISG54 and
Figure 1. Virologic analysis in wild type and IPS-1
2/2 mice. Adult wild type and IPS-1
2/2 mice were infected s.c. with 100 PFU of WN-TX. (A)
Differential lethality from WNV infection (WT n=13; IPS-1
2/2 n=23; p,0.0001). B–F. Viral burden analysis of peripheral and CNS tissues from wild
type and IPS-1
2/2 mice infected s.c. with 100 PFU of WN-TX. (B) WNV RNA in serum and infectious virus in the (C) spleen, (D) kidney, (E) brain, and (F)
spinal cord were determined by RT-qPCR assay (B) or viral plaque assay (C–F) of samples harvested on day 1, 2, 4, and 6 pi. Data are shown as copies
of WNV genome RNA per ml of serum or PFU per gram of tissue for 3 to 6 mice per timepoint. Graphs show the mean +/2 standard deviation for
each measurement. Asterisk denotes p,0.05. The horizontal line indicates the lower limit of assay sensitivity.
doi:10.1371/journal.ppat.1000757.g001
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induced during WNV infection of IPS-1
2/2 DCs (Fig 2C).
Moreover, ISG56, another IRF-3 target gene [31], was induced
late during infection and to lower levels as compared to
ISG54 and ISG49 in wild type, infected DCs. WNV infection
of IPS-1
2/2 Mw resulted in significantly higher virus replication
between 24 and 48 hours pi as compared to infected wild type
cells (Fig 2D). Whereas wild type infected Mw expressed IFN-b,
this response was completely abolished in IPS-1
2/2 Mw (Fig 2F).
We also observed a differential expression of ISGs and IRF-3-
target genes within WNV-infected Mw. RIG-I, MDA5, and
STAT-1 were not induced in IPS-1
2/2 Mw,w h e r e a s ,I S G 5 6 ,
ISG49, and PKR were expressed at reduced levels and with
delayed kinetics. These data establish that IPS-1-dependent RLR
signaling is the major innate immune signaling pathway that
controls virus replication in conventional DCs and Mw.
The RLR signaling pathway triggers the innate immune
response to WNV infection in primary cortical neurons
Neurons represent the target cell of WNV infection in the CNS
and their death after infection is a key factor in pathogenesis and
neurological sequelae [32,33]. To define the role of RLR signaling
in restricting virus replication in neurons, primary cortical neurons
were generated from wild type and IPS-1
2/2 mice. Cells were
infected at an MOI of 1.0 with WN-TX and virus yield, IFN-b
induction, and ISG expression were evaluated. In the absence of
IPS-1, WNV replicated faster and to higher levels resulting in a 2.2
and 4.2-fold (p,0.05) increase in viral production at 24 hrs and 48
Figure 2. IPS-1 is essential for triggering the innate immune response to WNV infection and controlling virus replication in myeloid
cells. Primary bone-marrow derived dendritic cells (A–C) and macrophages (D–F) recovered from wild type mice and IPS-1
2/2 mice were mock-
infected (M) or infected with WN-TX at an MOI of 1.0. Cells and culture media were harvested at the times indicated pi for determination of virus load
(A, D) and IFN-b production (B, E), respectively. n.d.=not detected. Graphs show the mean +/2 standard deviation from three independent
experiments. Asterisk denotes p,0.05. (C,F) Immunoblot analysis of protein abundance in lysates from mock-infected (M) and WN-TX infected cells.
For panel C, STAT-1 expression in dendritic cells was normalized at each timepoint to loading control and compared to mock (relative fold induction
WT, KO at 12 hours 1.72, 0.7; 24 hours 2.6, 0.8; 36 hours 4.6, 1.1; 48 hours 9.9, 0.6).
doi:10.1371/journal.ppat.1000757.g002
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(Fig 3A). This relatively modest virologic effect in neurons
compared to that observed in IPS-1
2/2 DC and Mw was
expected, as IFN-a or -b pre-treatment only inhibits WNV
infection in cortical neurons to a maximum of 5 to 8-fold [12],
suggesting that the IFN response is comparably less potent in
neurons. IFN-b expression was induced to lower levels in
IPS-1
2/2 neurons compared to wild type infected neurons at 24
(10-fold, p,0.05) and 36 hours pi (5-fold, p,0.05) despite the
higher levels of virus replication (Fig 3A and 3B). Expression of
ISGs, (including RIG-I and MDA5) and IRF-3 target genes
(including ISG56 and ISG49) followed this pattern and were
dependent on IPS-1 for rapid and high level expression (Fig 3C).
The presence of IFN-b and ISG transcripts in IPS-1
2/2 cells at
48 hrs pi is consistent with the finding that TLR3 has an
independent and subordinate role in triggering innate immune
responses in cortical neurons at later time points after WNV
infection [23]. These results demonstrate that the RLR signaling
pathway controls virus replication and induces innate immune
responses against WNV infection in cortical neurons.
Neuronal destruction and CNS inflammation are
enhanced in WNV infected IPS-1
2/2 mice
To determine the role of the RLR pathway in protection of
neurons against WNV pathogenesis in vivo, we conducted
histological analysis of brain tissue from wild type and IPS-1
2/2
mice infected with WN-TX (Fig 4A). Analysis of brain sections
from infected wild type mice revealed little or no inflammation or
Figure 3. IPS-1 is essential for triggering innate immune defenses and controlling virus replication during WNV infection of primary
cortical neurons. Primary cortical neurons (CN) from WT and IPS-1
2/2 mice were infected at an MOI of 1.0. (A) Viral titers in the culture supernatants
were determined by plaque assay. (B, C) mRNA expression was determined by RT-qPCR assay using primers-specific for (B) IFN-b or (C) ISG56, ISG49,
RIG-I, and MDA5. Graphs show the mean +/2 standard deviation from triplicate independent analyses. Asterisks denote p,0.05.
doi:10.1371/journal.ppat.1000757.g003
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2/2 mice. (A) H&E stained saggital brain tissue sections. The arrows denote
areas of interest. (B–E) Brain leukocytes were recovered from wild type and IPS-1
2/2 mice six days pi. (B) The total number of brain lymphocytes was
determined by cell counting. (C) Total CD4+ (left) and CD8+ T cells (right), (D) Total WNV-specific CD8+ T cells (left) with a representative analysis of
the frequency of TNF-a and IFN-c expression within brain CD8+ cells (right left), and (E) Total number of microglia/infiltrating macrophages (left) were
determined by flow cytometry (right; representative analysis). M=Mock; W=WN-TX. Data are representative of two or more independent
experiments, and each analysis represents a pool of 5 mouse brains.
doi:10.1371/journal.ppat.1000757.g004
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the hippocampus and cerebral cortex on day 6 pi. By day 10 pi (a
timepoint in wild type mice in which peak virus replication in the
CNS occurs [34]) cellular infiltrates were present in the
parenchyma and neuronal destruction was observed throughout
the cortex and hippocampus. In contrast, brain sections from
infected IPS-1
2/2 mice recovered on day 6 pi displayed extensive
injury to neurons in the cortex and granular neurons of the
hippocampus. Damaged neurons appeared pyknotic with vacuo-
lation, degeneration and cell dropout. Somewhat surprisingly, we
observed extensive inflammation in the brains from infected IPS-
1
2/2 mice within the cortex, hippocampus, and cerebellum (data
not shown) displaying prominent perivascular and parenchymal
immune cell infiltrates.
To evaluate the composition and antigen-specificity of the
inflammatory cells within the brains of WNV-infected mice,
lymphocytes were isolated from infected brains on day 6 pi and
were characterized from pools (n=5) of wild type and IPS-1
2/2
infected mice. Brains from IPS-1
2/2 infected mice showed an 2.9-
fold increase in the total number of immune cells as compared to
wild type infected mice (Fig 4B), and this was associated with an
increase in absolute numbers of infiltrating CD4+ and CD8+ T
cells (Fig 4C). Among the brain CD8+ T cells isolated from IPS-
1
2/2 mice, there was a remarkable 27-fold increase in the number
of antigen-specific cells that expressed IFN-c after treatment with
an immundominant NS4B peptide (Fig 4D) [35,36]. Analysis of
microglia/Mw cells, based on relative surface expression of CD45
and CD11b [37], revealed increased numbers of microglial cells
(CD45+
lo/CD11b+) and infiltrating macrophages (CD45+
hi/
CD11b+) within the brains of infected IPS-1
2/2 mice when
compared to wild type mice (Fig 4E). Similar findings were
observed in the spinal cords from infected IPS-1
2/2 mice (data
not shown). Combined with the histological analysis, these results
demonstrate that in the absence of IPS-1, WNV infection induces
a strong inflammatory response in the CNS. While this response is
likely associated with increased viral loads, the failure of this
increased inflammatory response to elicit protection or control
CNS pathology, in the absence of IPS-1, suggests a role for the
RLR signaling pathway as a regulatory program that controls the
quality of the inflammatory response to WNV infection.
Serum cytokine levels
To further characterize how IPS-1 modulates the inflammatory
response to WNV infection, we measured levels of systemic type I
IFN, proinflammatory cytokines, and chemokines present in the
serum of WNV-infected mice at 1 and 4 days pi. Paradoxically, a
trend towards more rapid induction and increased levels of type I
IFN were observed in the serum of IPS-1
2/2 mice compared to
wild type mice (Fig 5A). We note that in this case type I IFN was
detected and quantified through a mouse-specific type I IFN
bioassay, which does not differentiate between the IFN-a or -b
species. This result is consistent with our recent studies showing
that serum type I IFN levels accumulate during WNV infection in
an IRF-7-dependent but IRF-3-independent manner [8,9]. In this
case IFN-a species are likely accumulating through a TLR7-
dependent signaling pathway involving plasmacytoid DCs, which
do not require the RLR pathway for IFN production [38]. More
recently, Town et al. assessed the role of TLR7 and MyD88
2/2
during WNV infection and found that mice lacking MyD88
produced elevated levels of systemic IFN during WNV infection
[25]. Thus, during WNV infection systemic IFN is regulated
through RLR-dependent and independent processes. Correspond-
ingly, when compared to wild type mice, IPS-1
2/2 infected
animals, which show higher viremia (Fig 1B) produced increased
serum levels of proinflammatory cytokines and chemokines in
response to WNV infection. Elevated levels of systemic IL-6, TNF-
a, CXCL10, and IFN-c were observed at 1 and/or 4 days pi in
IPS-1
2/2 mice (Fig 5B). Serum cytokine levels were also
compared between uninfected wild type and IPS-1
2/2 mice and
showed no differences in basal cytokine expression (data not
shown). These results demonstrate that in the absence of IPS-1,
greater proinflammatory cytokine and chemokine responses are
induced during WNV infection.
Altered WNV-specific antibody profiles in IPS-1
2/2 mice
WNV-specific antibody responses are essential for suppressing
viremia and virus dissemination and limiting lethal WNV infection
[39,40]. To determine if a deficiency in IPS-1 modulated the
quality and quantity of the humoral immune response, we
characterized the antibody profile in sera during WNV infection.
In wild type mice, neutralizing virus-specific IgM antibodies are
typically detectable by day 4 pi with WNV and production of
neutralizing virus-specific IgG antibodies follow between days 6
and 8 pi [40]. A time course analysis in wild type and IPS-1
2/2
infected mice showed that between 4 and 6 days pi, WNV-infected
IPS-1
2/2 mice exhibited significantly higher levels of virus-specific
IgM, IgG, and IgG subclasses as compared to infected wild type
mice (Table 1). WNV-specific IgG1 antibodies were detected at
low levels on day 6 pi in sera from wild type and IPS-1
2/2 mice.
Additionally, we observed a ,72.9-fold increase in WNV-specific
IgG2a levels in infected IPS-1
2/2 as compared to wild type mice
on day 6 pi and ,2.2-fold increase on day 8 pi. Assessment of
the virus-specific antibody responses through a PRNT assay
revealed that neutralization titers in sera from wild type mice
increased dramatically between 6 and 8 days pi. Sera from
IPS-1
2/2 infected mice exhibited a modest increase in neutral-
ization titer to 1:1280, despite having much higher levels of virus-
specific antibodies. This difference translated into a serum
neutralization index that was ,39-fold lower on day 6 pi in the
infected IPS-1
2/2 mice compared to wild type mice. These results
demonstrate that the humoral responses in WNV-infected
IPS-1
2/2 mice are distinct from responses in wild type infected
mice. Thus, RLR signaling and IPS-1 actions likely contribute to
regulatory processes that govern the levels, IgG class switching,
and neutralizing capacity of antibodies generated in response to
WNV infection.
Enhanced inflammation in lymphoid organs associates
with altered DC subsets and reduced numbers of
regulatory T (Treg) cells in WNV infected IPS-1
2/2 mice
To characterize the immune parameters associating with the
dysregulated inflammatory and humoral responses in WNV
infected IPS-1
2/2 mice, we analyzed the immune cell composition
in draining lymph node and spleen tissues. Wild type and
IPS-1
2/2 mice were challenged with diluent alone or with WN-
TX, and draining popliteal lymph node (DLN) and the spleen
were harvested at 1 and 6 days pi, respectively. Analysis of the
popliteal DLN provides insight into how IPS-1 modulates the
inflammatory response immediately after infection whereas
assessment of the spleen elucidates characteristics of the adaptive
immune response prior to the infection endpoint. Immune cells
were isolated from the popliteal DLN and were characterized by
flow cytometry (Fig 6). Analysis of CD8a DC subsets, which are
phenotypically the major antigen presenting cells within lymphoid
tissues and are implicated in eliciting virus-specific CD8 T cell in
response to acute WNV infection [41], showed that infected wild
type and IPS-1
2/2 mice exhibited similar increases in the
IPS-1 Is Essential for Immunity to WNV Infection
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+ and CD8a
2 DCs compared to mock-infected
mice (Fig 6A, B). However, a significant increase (,3-fold;
p,0.05) of a proinflammatory DC subset, characterized as
CD11c
+CD11b
hiLy6C
+, was observed within the popliteal DLNs
of IPS-1
2/2 infected mice (Fig 6C). This DC subset is monocyte-
derived and typically recruited to sites of acute inflammation
where they propagate the inflammatory response [42]. We found
that these DC subsets were not significantly expanded and showed
no differences in their recruitment to the DLN in either wild type
or IPS-1
2/2 infected mice at 12 hours pi (data now shown). Thus,
as early as 24 hours pi, an elevated cellular inflammatory response
is initiated in the IPS-1
2/2 mice. In contrast, similar increases in
plasmacytoid DCs were observed within infected wild type and
IPS-1
2/2 infected mice (Fig 6D), demonstrating that an absence
of IPS-1 did not directly affect expansion and/or recruitment of
this DC subset. Within the popliteal DLNs, mock-infected
IPS-1
2/2 mice compared to wild type mice generally showed
elevated numbers of B cells, CD4+ T cells (p,0.05), and CD8+ T
cells (Fig 6E, F, and G). These results suggest that IPS-1
contributes to the homeostasis of lymphocyte populations within
LNs. WNV infection of wild type mice increased the number of B
cells (3.4 fold), CD4
+ T cells (3.1 fold), and CD8
+ T cells (2.3 fold;
p,0.05) in the DLN within 24 hours pi. Similar increases in B
cells were observed upon infection of IPS-1
2/2 mice. However,
the number of CD4
+ and CD8
+ T cells was reduced in the DLN
after WNV infection of IPS-1
2/2 mice. Thus, in the absence of
Figure 5. Enhanced levels of IFN, proinflammatory cytokines, and chemokines in serum from WNV-infected IPS-1
2/2 mice. Serum
was collected from wild type and IPS-1
2/2 mice. (A) Type I IFN levels at 1, 2, and 4 days pi. (B) Proinflammatory cytokines and chemokines were
measured on days 1 and 4 pi. Graphs show the mean +/2 standard deviation from triplicate measurements of duplicate experiments. Asterisks
denote p,0.001.
doi:10.1371/journal.ppat.1000757.g005
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PLoS Pathogens | www.plospathogens.org 8 February 2010 | Volume 6 | Issue 2 | e1000757IPS-1, WNV infection specifically increases the number of
inflammatory Ly6c
+ DCs but suppresses the overall expansion
and/or recruitment of T cells in the DLN.
We further analyzed the lymphocyte composition of the
spleen on day 6 after WNV infection (Fig 7). Gross pathologic
analysis revealed that WNV infection of IPS-1
2/2 mice results
in massive splenomegaly whereas infection of wild type mice
induces only a slight increase in spleen size (Fig 7A). Cell
analysis revealed increased numbers of total lymphocytes in the
spleens of infected IPS-1
2/2 mice as compared to wild type
mice (Fig 7B).
Regulatory T (Treg) cells have recently been shown to contribute
to the dampening of inflammation and adaptive immune
responses during acute virus infections [26,43,44]. Moreover, a
reduction in the number of circulating Treg in mice leads to
enhanced lethality after WNV infection [45]. A time course
analysis of Tregs in wild type mice revealed that WNV infection
results in a significant increase in the numbers of FoxP3+ T cells as
compared to mock-infected mice beginning on day 4 and peaking
by day 6 pi (Fig 7C), indicating the expansion of Tregs during
acute WNV infection. Despite their marked increase in viral load,
the infected IPS-1
2/2 mice did not display an increase in the
numbers of FoxP3+ T cells at any timepoint analyzed. Thus, IPS-1
signaling directly or indirectly impacts Treg proliferation and does
so independently of viral load.
We also observed that spleens from infected IPS-1
2/2 mice
exhibited significantly increased numbers of CD8+ T cells in
comparison to those from infected wild type mice, whereas the
expansion of splenic CD4+ T cells in wild type and IPS-1
2/2 mice
were not different (Fig 7D). The spleens from WNV-infected IPS-
1
2/2 mice showed significantly higher numbers (3.9-fold; p,0.05)
of WNV-specific CD8+ T cells producing IFNc.
To further define the phenotype associated with WNV-induced
splenomegaly in IPS-1
2/2 mice, we also assessed the numbers
of NK cells and neutrophils. Spleens from infected IPS-1
2/2
mice contained greater numbers of NK cells (CD4
2
CD8
2NK1.1
+cells), NKT cells (CD4+/CD8+/NK1.1+ cells)
and neutrophils (CD11b
+Gr1
+ cells) (Fig 7E). Although WNV-
infected wild type mice infected displayed slight increases in the
absolute numbers of these specific cell types, a deficiency of IPS-1
resulted in a more marked enhancement of these immune cell
populations.
Discussion
In this study, we establish a major role for RLR signaling in
protection from WNV pathogenesis, and demonstrate that IPS-1 is
critical for the control of WNV infection in vivo. Our studies
indicate that IPS-1-dependent RLR signaling functions to establish
balanced, effective, and protective innate and adaptive immune
responses, and that IPS-1 links adaptive immune regulation with
the innate immunity triggered by RLR signaling during WNV
infection. In the absence of IPS-1 in vitro, innate immune defense
programs of myeloid DCs and macrophages were ablated or
severely attenuated. Moreover, in vivo analysis of infected IPS-1
2/
2 mice showed altered IgG and IgM antibody responses with
diminished virus neutralization activity. The inflammatory
response to WNV infection is regulated by IPS-1-dependent
processes such that a deficiency of IPS-1 resulted in elevated
proinflammatory cytokine and chemokines and increased numbers
of inflammatory DCs, antigen-specific T cells, natural killer cells,
and neutrophils in lymphoid organs, and activated macrophage/
microglial cells within the CNS. The dysregulated inflammatory
response to WNV infection in IPS-1
2/2 mice was associated with
a reduction in the numbers of Treg cells and their failure to expand
during acute infection. These observations demonstrate the critical
role of IPS-1 in mediating RLR signaling of innate antiviral
immunity against WNV infection, and reveal novel features of
IPS-1 function in regulating immune homeostasis, inflammation,
and adaptive immunity to infection.
Although infection of primary DCs, macrophages, and neuronal
cells failed to induce type I IFN upon WNV infection, WNV-
infected IPS-1
2/2 mice showed enhanced systemic type I IFN
responses. This finding agrees with previous studies that indicate
both IPS-1-dependent and -independent pathways contribute to
the systemic type I IFN production in vivo [8,9,23,25]. Most
importantly, the enhanced tissue tropism and rapid viral entry into
the CNS observed in the IPS-1
2/2 mice is not affected by the
elevated systemic IFN responses. This suggests that local tissue-
specific and intracellular responses triggered by RLR-dependent
signaling are more essential for reducing viral burden and
dissemination. One possible explanation is that a distinct set of
RLR-responsive genes function to control virus replication at the
site of infection. This could explain, in part, the elevated levels of
virus replication, enhanced tissue tropism and cell-to-cell spread in
mice or cells deficient in IRF3 or IRF-7, each of which are
downstream transcription factors of RLR signaling [8,9,10].
Additionally, it is likely that pDCs, which are specialized dendritic
cells for producing systemic type I IFN during a viral infection
[46], are likely contributing to the IFN responses observed during
WNV infection. Studies by Silva et al. have shown that WNV
triggers IFN induction in pDCs through a replication-independent
manner [47]. Interestingly, within the DLN, we observed similar
expansion of pDCs between wild type and IPS-1
2/2 infected
mice, yet at the same timepoint (24 hours pi), elevated systemic
type I IFN responses were observed in IPS-1
2/2 mice. This
suggests two possibilities: 1) splenic pDCs or circulating pDCs are
likely responding to the high levels virus in the serum from the
IPS-1
2/2 infected mice to produce IFN at 24 hours pi and/or 2)
various other cell types that express TLR3 and/or TLR7 are
responding to WNV infection and contributing to systemic IFN
responses. Taken together, these studies indicate that RLR
signaling and the actions of IRF-3/7 are important in triggering
IFN production and ISG expression to limit WNV replication and
spread, and that TLR signaling may impart additional, RLR-
independent defenses that regulate immunity against WNV
infection.
Table 1. WNV-specific antibody titers.
Wild type IPS-1
2/2
Day 4 Day 6 Day 8 Day 4 Day 6
IgM
a ,20 160649 1620604 7 620 162060
IgG
b 60605 2 0 6575 1215064860 40622 102060645174
IgG1
b ,20 2060 ,20 ,20 2060
IgG2a
b ,20 1266203 405061620 ,20 918066033
PRNT50 ,20 32060 704063840 ,20 128060
Neutralization
Index
c
,0.25 0.471 0.511 ,0.23 .012
aIgM titers were determined by an arbitrary cutoff at an OD of 0.2 minus the
value from mock infected mice.
bIgG, IgG1, and IgG2a titers determined by OD values that were greater than 3
standard deviations above background signal.
cNeutralization index was calculated by dividing PRNT50 titers by the total IgM
a
plus IgG
b titer for each point.
doi:10.1371/journal.ppat.1000757.t001
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PLoS Pathogens | www.plospathogens.org 9 February 2010 | Volume 6 | Issue 2 | e1000757Figure 6. Immune cell subsets within the popliteal draining lymph node during acute WNV infection. Wild type and IPS-1
2/2 mice were
mock-infected (M) or infected with WN-TX (W), and popliteal draining lymph nodes were harvested 24 hr later. Lymphoid cells were isolated and cells
were analyzed by flow cytometry. (A–C) total numbers of cells expressing various dendritic cell surface markers, (D) plasmacytoid cell surface markers
(CD11c
int/lo/B220+/siglec H+). (E and F) T cells (G) B cells. A representative flow cytometric analysis of the CD11c+/CD11b
hi/Ly6C+ DC subset is shown
in C (left panel set). Data show the mean +/2 standard deviation from triplicate samples of duplicate experiments. Asterisks denote p,0.05.
doi:10.1371/journal.ppat.1000757.g006
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PLoS Pathogens | www.plospathogens.org 10 February 2010 | Volume 6 | Issue 2 | e1000757The production of and response to type-I IFN is a major linkage
point between innate and adaptive immunity, as IFN-a and IFN-b
sustain B cell activation and differentiation [48,49,50], expand
antigen-specific CD8+ T cells [51,52], CD4+ T cells [53], and
activation of NK cells [54]. One of the most intriguing aspects of
this study was the global alteration of the immune response elicited
in the IPS-1
2/2 mice, indicating that RLR signaling couples
innate immunity with regulation of the adaptive immune response.
Infection of IPS-1
2/2 mice exhibited increased IgM and IgG
WNV-specific antibodies, enhanced WNV-specific CD8+T cell
Figure 7. Enhanced inflammation in IPS-1
2/2 infected mice associates with a lack of Treg expansion during WNV infection. Wild type
and IPS-1
2/2 mice were mock-infected (M) or infected with WN-TX (W). Spleens were harvested and immune cells were isolated, counted, and
characterized by flow cytometry. (A) Spleen morphology. (B) Absolute cell counts. (C) Total CD4+/FoxP3+ regulatory T cells (left; M=mock) and
representative flow cytometric analysis of cell frequency from samples on day 6 pi (right). (D) CD4+ and CD8+ T cells. (E) NS4B antigen-specific CD8+ T
cells. (F) CD42/CD82/NK1.1+ NK cells, CD4+/CD8+/NK1.1+ NKT cells, and CD11c+/Gr1+ neutrophils. Graphs show the mean +/2 standard deviation
from triplicate samples of duplicate experiments. Asterisks denote p,0.05.
doi:10.1371/journal.ppat.1000757.g007
IPS-1 Is Essential for Immunity to WNV Infection
PLoS Pathogens | www.plospathogens.org 11 February 2010 | Volume 6 | Issue 2 | e1000757response, and increased expansion of neutrophils, NK cells and
NK-T cells. One trivial explanation for these differences is that
there is an increased antigen load in the absence of IPS-1 and, as a
result, enhanced virus-specific (e.g. CD8+ T cells, IgG and IgM
antibodies) and nonspecific (e.g. Neutrophils, NK cells) responses.
However, there are several key findings from this study that argue
against these responses simply being attributed to higher antigen
load: (1) In the absence of IPS-1, the CD4 and CD8 T cells, which
are protective against WNV infection [34,35,36,55,56,57,58],
were significantly enhanced in the peripheral and CNS compart-
ments but failed protect against infection. One explanation for this
observation is that the expansion and migration of CD4 and CD8
T cells to different tissues was itself uncontrolled, resulting in T
cell-mediated pathology rather than T cell-mediated protection.
(2) While the quantity of virus-specific IgM and IgG antibody
responses were greatly enhanced in the absence of IPS-1, there
was a marked reduction in antibody quality in terms of
neutralization capacity. In contrast deficiencies in TLR3 or
MyD88 (data not shown) did not alter virus-specific antibody
responses and neutralization capacities. Collectively, these findings
suggest that RLR-dependent signaling coordinates effective
antibody responses during WNV infection through as yet
undefined pathway. (3) While systemic IFN responses provide a
link between innate and adaptive immune responses, our studies
suggest that the PRR signaling pathways (RLR-dependent vs –
independent) and levels of IFN production in combination with
production other proinflammatory cytokines or chemokines
regulate the quantity and quality of the immune response during
virus infection. Thus, in the absence of IPS-1 signaling, infected
conventional DCs or Mw, two integral cell types in establishing
adaptive immunity, likely do not produce IFN or the normal array
and level of proinflammatory cytokines/ chemokines. Instead, IFN
and other mediators may be strictly produced by infected or
bystander cells during WNV infection, occurring with altered
kinetics and magnitude, through TLR-dependent pathways, such
as TLR3 and/or TLR7 [23,25]. (4) In the absence of IPS-1, the
enhanced expansion of Ly6C+ ‘‘inflammatory’’ DCs failed to limit
early WNV replication and dissemination. This inflammatory DC
subset migrates to sites of infection, secretes pro-inflammatory
cytokines, and promotes CD8+ T cell expansion during a
secondary virus infection, suggesting it sustains the effector T cell
response [59]. Our data indicate that Ly6C+ DC recruitment
and/or expansion is governed by IPS-1-dependent events of RLR
signaling. Thus, the aberrant recruitment/expansion of these
inflammatory DCs may contribute to immunopathogenesis and
limit development of an effective immune response to control
WNV virus infection. (5) The lack of Treg expansion during WNV
infection correlated with altered IFN levels, increased proinflam-
matory cytokines and chemokine levels, and an increased number
and distribution of antigen-specific CD8+ T cells. These
observations implicate an indirect or direct role for IPS-1 in
regulating Treg levels during WNV infection, and provide evidence
that links a lack of Treg expansion to immune dysregulation.
While their importance in autoimmunity is established [60],
recent studies have implicated an integral role for Tregs in
controlling inflammation and adaptive immune responses during
acute virus infections [26,43,44]. During acute infection Tregs
function to locally contain and control the immune response with
the dual outcome of suppressing viral dissemination while
decreasing the likelihood of immune-mediated pathology. In
support of this model, infection studies with herpes simplex virus
(HSV) and mouse hepatitis virus (MHV), two well established
models of viral encephalitis, have demonstrated the importance of
Tregs in limiting proinflammatory cytokine and chemokine
responses to protect the CNS and enhance survival [26,43].
Recent work also implicates Tregs in the control of WNV
pathogenesis, wherein peripheral expansion of Tregs was associated
with asymptomatic infection among WNV-infected blood donors
but reduced Treg levels associated with WNV disease [45].
Furthermore, these studies revealed that the conditional depletion
of Treg cells in mice results in enhancement of WNV virulence and
expansion of antigen-specific CD8 T cells. Interestingly, from our
studies, type I IFN does not appear to be the major contributor to
Treg expansion during WNV infection, as Tregs failed to expand in
the IPS-1
2/2 infected mice despite their elevated levels of systemic
type IFN. These observations suggest that RLR signaling through
IPS-1 provides essential signals that directly or indirectly impart
the expansion of Tregs during WNV infection.
We propose that IPS-1 coordinates an innate/adaptive immune
interface wherein IPS-1- signaling after RLR engagement
regulates the quantity, quality, and balance of the subsequent
immune response. The integrity of the innate/adaptive immune
interface is central to the eliminating virus but also restricting
immunopathogenesis and inflammation during infection. RLR
signaling is essential for triggering the innate immune response to
RNA viruses that cause human disease, including the influenza
viruses, respiratory syncytial virus and other paramyxoviruses,
picornaviruses, reoviruses, flaviviruses, and hepatitis C virus
[14,19,22]. Thus, in addition to WNV, IPS-1-dependent RLR
signaling will likely have a broad impact for the control of
inflammation, immune response quality, and viral disease.
Methods
Cells and viruses
BHK21 and L929 cells were maintained in Dulbecco’s modified
Eagle medium (DMEM) supplemented with 10% fetal bovine
serum (FBS), 2mM L-glutamine, 1 mM sodium pyruvate,
antibiotic-antimycotic solution, and 16 nonessential amino acids
(complete DMEM). WNV strain TX 2002-HC (WN-TX) was
isolated by as previously described [11]. Working stocks of WN-
TX were generated by a single round of amplification on Vero-E6
(ccl-81; ATCC) cells, and supernatants were collected, aliquoted,
and stored at 280uC. Virus stocks were titered by a standard
plaque assay on BHK21 cells as previously described [40].
Mouse experiments
IPS-1
2/2 (C57BL/66129Sv/Ev) and their wild type littermate
control mice have been published [38,61] and were obtained as a
generous gift from Dr. S. Akira (Osaka University, Osaka, Japan).
Mice were genotyped and bred under pathogen-free conditions in
the animal facility at the University of Washington. Experiments
were performed with approval from the University of Washington
Institutional Animal Care and Use Committee. The methods for
mice use and care were performed in accordance with the
University of Washington Institutional Animal Care and Use
Committee guidelines. Age-matched six to twelve week old mice
were inoculated subcutaneously (s.c.) in the left rear footpad with
100 PFU of WN-TX in a 10 ml inoculum diluted in Hanks
balanced salt solution (HBSS) supplemented with 1% heat-
inactivated FBS. Mice were monitored daily for morbidity and
mortality.
Viral tissue burden and quantification
For in vivo virus replication studies, infected mice were
euthanized, bled, and perfused with 20 ml of phosphate-buffered
saline (PBS). Whole brain, spinal cord, kidney, and spleen were
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plaque assay.
Primary cell isolation and infection
Bone-marrow derived DC and Mw were generated as described
previously [9]. Briefly, bone marrow cells from wild type and
congenic deficient mice were isolated and cultured for 7 days in
either RPMI-1640 supplemented with granulocyte-macrophage-
colony stimulating factor, and interleukin-4 (Peprotech) to
generate myeloid DC or in DMEM supplemented with macro-
phage colony stimulating factor (Peprotech) to generate Mw.O n
day 7, DC or Mw were infected with WN-TX at an MOI of 1.0
and at 12, 24, 36, and 48 hours post-infection (hpi), supernatants
were collected for titration of viral burden by plaque assay on
BHK21 cells and levels of IFN-b (described below). Cells were
collected in parallel for western blot analysis. Cortical neurons
were isolated from 15-day-old embryonic mice and cultured as
described previously [62]. On day 6 of culture, neurons were
infected with WN-TX at an MOI of 1.0 and at 12, 24, 36, and
48 hpi, supernatants were collected for virus titration by plaque
assay on BHK21 cells and cells were collected for RNA analysis by
RT-qPCR (described below).
Western blot analysis
Cells were lysed in modified RIPA buffer (10mM Tris [pH 7.5],
150mM NaCl, 0.5% sodium deoxycholate, and 1% Triton X-100)
supplemented with protease inhibitor cocktail (Sigma) and
phosphatase inhibitor cocktail II (Calbiochem). Protein extracts
(25 mg) were analyzed by immunoblotting as described previously
[11]. The following primary antibodies were used to probe blots:
mouse anti-WNV from the Center for Disease Control; rabbit
anti-ISG56, rabbit anti-ISG54, rabbit anti-ISG49, kindly provided
by Dr. G. Sen; mouse anti-PKR from Santa Cruz; rabbit anti-
RIG-I and rabbit anti-MDA5 from IBL; mouse anti-tubulin from
Sigma; and rabbit anti-STAT-1 from Cell signaling. Secondary
antibodies included peroxidase-conjugated goat anti-rabbit, goat
anti-mouse, donkey anti-rabbit, and donkey anti-mouse were from
Jackson Immunoresearch.
RNA extraction and analysis
For analysis of viremia, serum was separated (BD Microtainer
tube SST) and RNA was extracted as previously described [8].
WNV RNA copy number was measured by RT-quantitative PCR
(RT-qPCR) as previously described [63]. For cultured cells, total
RNA was extracted using the RNeasy kit (Qiagen), DNase treated
(Ambion) and evaluated for ISG49, ISG56, IFN-b, RIG-I, and
MDA5 RNA expression by one-step SYBR Green RT-qPCR.
Specific primer sets for ISG-49, ISG-56, RIG-I, and IFN-b have
been described previously [30,64]. Primer sets for MDA5 are: 59-
GTGGTCGAGCCAGAGCTGAT and 39- TGTCTCATG-
TTCGATAACTCCTGAA.
Interferon bioassay and ELISA
IFN-a and -b were measured in sera using a biological assay as
previously described [65]. Briefly, L929 cells were seeded at 3610
4
cells/well in a 96 well plate one day prior to the addition of
interferon standards or experimental samples. Mouse sera (diluted
1:10 in L929 media) were treated with UV light for 20 minutes to
eliminate residual virus. Duplicate sera samples were then added
to the 96-well plates in two-fold dilutions along with a murine IFN-
b standard. The following day, EMCV challenge virus was added
to the cells in 50 ml/well at an MOI of 5.0. Twenty-four hours
later, cytopathic effect was measured by a blinded scorer and IFN
levels in the sera was calculated based on the IFN standard. IFN-b
in cell culture supernatants was analyzed using mouse-specific
ELISA kits from PBL Biomedical Laboratories according to the
manufacturer’s protocol.
WNV-specific antibody analysis
WNV-specific IgM, total IgG, IgG1, and IgG2a levels were
determined by an ELISA using purified recombinant E protein as
previously described [55]. The neutralization titer of serum
antibody was determined by using a previously described plaque
reduction neutralization assay [40]. Briefly, sera samples from
mock or WN-TX infected mice were diluted in DMEM followed
by incubation at 56uC for 30 minutes to inactivate virus and
complement factors. Sera were further diluted in two-fold
increments and incubated with 100 PFU of WN-TX at 37uC for
1 hour. Standard plaque assays were performed on BHK21 cells
and the dilution at which 50% of plaques were neutralized was
determined by comparing the number of plaques formed from
WNV-infected sera samples to mock infected sera samples.
Cytokine/chemokine analysis
WNV infected sera were analyzed for the presence and levels of
TNF-a, IFN-c, CXCL10 (IP-10), and IL-6 by a mouse-specific
cytokine/chemokine Milliplex ELISA (Millipore).
Histological analysis
Mock-infected or WNV-infected mice were exsanguinated and
perfused with PBS, 4% paraformaldehyde, pH 7.3. Brains were
embedded in paraffin and 10-mm sections were prepared and
stained with hematoxylin and eosin (H&E) by the UW histology
pathology laboratory. Sections were analyzed using a Nikon
Eclipse E600 microscope (UW Keck microscope facility).
Flow cytometric analysis
Draining lymph nodes from mice were isolated and digested
with collagenase (Roche) and type I DNase in serum-free RPMI
media at 37uC for 40 minutes with mechanical disruption. Cells
were then incubated with RPMI media containing 10% FBS with
EDTA and HEPES for 10 minutes at room temperature, pelleted,
and resuspended in PBS containing 2% FBS and 0.1% sodium
azide (FACS Staining buffer). Splenocytes were isolated, washed,
and re-suspended in RPMI 1640 containing 10% FBS before in
vitro stimulation. Cells were washed twice before FACS staining.
For isolation of CNS immune cells, mice were euthanized and
perfused extensively with PBS to remove residual intravascular
leukocytes. Brains and spinal cords from 5 mice per experimental
group were isolated and pooled. Tissues were minced in RPMI
media, triturated, and digested with Liberase (Roche) and type I
DNase in serum-free RPMI media at 37uC for 45 min. Immune
cells were isolated after gradient centrifugation from a 37/70%
Percoll interface and washed twice with FACS staining buffer.
Immune cells were stained with antibodies specific to CD11c,
CD11b, B220, CD3, CD25, CD4, CD8, NK1.1, Gr-1, siglec H,
and CD45 (all reagents from eBiosciences). Intracellular FoxP3
staining was performed as previously described [26]. Intracellular
IFN-c staining was performed on splenocytes and CNS immune
cells as previous described [35,36]. Briefly, lymphocytes were
stimulated with 1 mg/ml of the WNV NS4B peptide (SSVWNAT-
TAI) for 4 h at 37uC. Cells were washed and stained for cell
surface markers followed by permeabilization-fixation using the
Cytofix-Cytoperm Kit (BD-PharMingen) and stained with a
Pacific-Blue conjugated IFN-c antibody (eBiosciences) at 4uC for
30 min, washed and analyzed by flow cytometry. Flow cytometry
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software. Cell analysis was performed on FlowJo (v.8.7.2) software.
Statistical analysis
For in vitro studies and immune cell analysis an unpaired student
T-test was used to determine statistical differences. For in vivo viral
burden analysis, Mann-Whitney analysis was used to determine
statistical differences. Kaplan-Meier survival curves were analyzed
by the log-rank test. A p-value#0.05 was considered significant.
All data were analyzed using Prism software (GraphPad Prism5).
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